Litigation

Recent Posts

Yasmin, Yaz Gallbladder Cases Settled For $24 Million By Bayer; Payouts Are $2,000-$3,000
Posted on 18 Mar 2013 by Tom Moylan

EAST ST. LOUIS, Ill. — (Mealey’s) Bayer HealthCare Pharmaceuticals Inc. will pay $24 million to resolve claims of plaintiffs who allege that they developed gallbladder disease or underwent gallbladder surgery as a result of using Yasmin or... Read More

Tags: gallbladder disease , In Re: Yasmin and Yaz [Drospirenone] Marketing , drospirenone , Bayer HealthCare Pharmaceuticals , Litigation , multidistrict litigation , Yaz , Gallbladder Resolution Program , Settlement , birth control pills , Yasmin , Sales Practices and Products Liability Litigation , drugs and medical devices

Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting
Posted on 7 Dec 2011 by Thomas J. Lamb

Coincidence, But Ironic, Given Several Recent Medical Studies Which Suggest Drospirenone (DRSP) Causes Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com ) On November 29, 2011 Watson Pharmaceuticals issued this press release, "Watson's... Read More

Tags: Gianvi , drug injury , drospirenone , Ocella , Syeda , drug safety , Safyral , Beyaz , FDA , Loryna , Zarah , blood clots , Yaz , Yasmin , DRSP , Vestura , side effects